Fevipiprant is used in the oral treatment of asthma and has been successful in targeting severe eosinophilic asthma. Fevipiprant is a novel oral prostaglandin D2 receptor 2 (DP2, known as CRTh2) antagonist and currently in development for the treatment o
Molekulargewicht:
426.41
CAS Nummer:
[872365-14-5]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten